Fear of cancer recurrence in oncology follow-up: Prevalence and the role of patient–oncologist communication.
Abstract
e24101 Background: Fear of cancer recurrence (FCR) is one of the most frequent and least addressed concerns among patients in oncological follow-up. Its impact on quality of life and emotional well-being has been widely documented, but its systematic evaluation and management in clinical practice remain insufficient. Objective: To assess the prevalence of FCR in a cohort of patients in oncological follow-up and to analyze its association with sociodemographic and clinical variables. Additionally, to explore the interaction between patients and oncologists regarding FCR, focusing on doctor–patient communication and support during consultations. Methods: Cross-sectional study using the Cancer Worry Scale and a structured questionnaire that inquired about doctor–patient dialogue, strategies provided, and desired support. A total of 153 patients in cancer follow-up were included, excluding those under active treatment. Bivariate analyses were performed according to age, educational level, sex, stage, tumor site, and time since diagnosis. Results: A total of 153 patients were included (median age 66 years, 53.6% women). According to the CWS, 26.1% showed high FCR, 29.4% moderate, and 44.4% low. High FCR was more frequent in younger patients, those with higher educational level, advanced stage, and shorter time since diagnosis (p < 0.05). Nearly half (48.4%) discussed FCR with their oncologist, and 15.7% did so in more than one consultation; among those who did not address it, the main reason was not considering it a problem (65.8%). High FCR was associated with lack of opportunity during consultation and with medical strategies perceived as not useful. Conclusions: FCR is frequent among patients in oncological follow-up and is more closely related to sociodemographic than clinical factors. Doctor–patient communication plays a central role in its management. These findings highlight the need for systematic evaluation and support strategies tailored to each patient’s profile, in order to provide more equitable and person-centered care.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (14)
Natalia Camejo
Servicio de Oncologia Clinica, Hospital de Clínicas, University of Uruguay, Montevideo, Uruguay
Cecilia Castillo
Hospital de Clínicas, Montevideo, Uruguay
Dahiana Amarillo
Hospital de Clinicas, Montevideo, Uruguay
Guadalupe Herrera
Unidad Académica de Medicina Preventiva y Social. Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
Virginia Suaya
Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
Ivan Lyra-Gonzalez
Departamento de Oncologia Clinica, Hospital de Clinicas, Universidad de la Republica, Montevideo, Uruguay
Noelia Strazzarino
Hospital de Clinicas, Montevideo, Uruguay
Lucia Argenzio
Hospital de Clínicas, Montevdeio, Uruguay
Joaquin Manzanares
Servicio de Oncologia Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay
Belen Insagaray
Servicio de OncologÍa Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay
Dahianna Tarde
Servicio de Oncología Clínica, Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay
Lujan Cabrera
Hospital Departamental de Soriano "Zoilo A. Chelle", Soriano, Uruguay
Joselina Ibarburu
Hospital Departamental de Soriano "Zoilo A. Chelle", Soriano, Uruguay
Gabriel David Krygier
Hospital de Clinicas, Montevideo, Uruguay